文献速递胃肠外科围术期管理与 ERAS

机器人结肠切除经自然腔道与腹壁取标本的疼痛及阿片类药物使用比较

Pain and opioid use after robotic colectomy with natural orifice vs abdominal wall extraction: a single-institution analysis.
PubMed 文献 · Surg Endosc · 2025-08-18

单中心回顾性分析比较机器人前切除术(乙状结肠切除)治疗憩室病后,经自然腔道取标本与腹壁取标本的术后疼痛及阿片类药物使用。结果显示两组术后阿片类药物用量(以吗啡毫当量计)无显著差异(aOR 1.21,p=0.59),术后并发症亦无显著差异(腹壁组8.1% vs 自然腔道组13.0%)。

要点

  • 经自然腔道取标本与腹壁取标本的术后阿片类药物用量无显著差异。
  • 两组术后并发症无显著差异(腹壁组8.1% vs 自然腔道组13.0%)。
  • 术前疼痛较低和心理健康较好与术后无需阿片类药物相关。

核心结论

  • 对于憩室病行机器人前切除术,经自然腔道取标本与腹壁取标本在术后疼痛、阿片类药物使用及并发症方面无显著差异。

研究设计与样本

  • 单中心回顾性分析,比较2021年1月1日至2024年11月21日前瞻性维护的机构结直肠手术数据库中因憩室病行机器人前切除术的251例患者,其中腹壁取标本136例,自然腔道取标本115例。

主要发现

  • 术后阿片类药物用量(以吗啡毫当量计)在自然腔道组与腹壁组间无显著差异(aOR 1.21,p=0.59)。
  • 20.7%的研究人群术后无需阿片类药物。
  • 术前疼痛较低(aOR 0.73,p=0.02)和心理健康较好(aOR 1.05,p=0.05)与术后无需阿片类药物相关。
  • 患者报告的术前PROMIS-10疼痛评分和较年轻年龄与更高的术后数字疼痛评分相关。
  • 术后并发症两组无显著差异(腹壁组8.1% vs 自然腔道组13.0%)。

临床怎么用

  • 在选择标本取出部位时,应告知患者经自然腔道取标本并未显著减少术后疼痛或阿片类药物使用。
  • 术后疼痛管理可关注术前疼痛较低和心理健康较好的患者,其可能无需阿片类药物。

局限性

  • 本研究为单中心回顾性分析,结论需谨慎推广。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The specimen extraction incision is the largest during minimally invasive colectomy and conceivably the most painful. We recently adopted natural orifice extraction through the rectum or vagina, leaving only port site incisions for abdominal wall pain. Previous studies demonstrating natural orifice extraction advantages are inconclusive. The study aim was to determine if natural orifice specimen extraction is associated with less pain and opioid use than abdominal wall specimen extraction after enhanced recovery robotic anterior (sigmoid) resection for benign disease. METHODS: This is a single-institution retrospective analysis comparing abdominal wall and natural orifice extraction sites after robotic anterior resection for diverticular disease in a prospectively maintained institutional colorectal surgery database from 1/1/2021 to 11/21/2024. The primary outcomes were postoperative opioid use measured by morphine milliequivalents analyzed with generalized linear models and postoperative pain scores analyzed with ordinal logistic regression models. RESULTS: There were 251 anterior (sigmoid) resections for diverticular disease, 136 patients with abdominal wall specimen extraction sites, and 115 patients with natural orifice extraction. Patient characteristics were well matched between groups. One-fifth (20.7%) of the study population required no postoperative opioids. There was no significant difference in postoperative opioids, measured by morphine milliequivalents, between natural orifice and abdominal wall extraction site groups (aOR1.21, p = 0.59). Lower preoperative pain (aOR0.73, p = 0.02) and better mental health (aOR1.05, p = 0.05) were associated with no postoperative opioids. Patient-reported preoperative PROMIS-10 pain scores and younger age were associated with higher postoperative numeric pain scores. There was no significant difference in postoperative complications between groups (abdominal wall 8.1% vs natural orifice 13.0%). CONCLUSION: There was no significant difference between abdominal wall and natural orifice extraction in postoperative pain, postoperative opioids, and complications after robotic anterior resection for diverticular disease. These data may assist targeting postoperative pain solutions and counsel patients considering specimen extraction site options.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Baur K, Brockhaus KK, Huebner M, et al. Pain and opioid use after robotic colectomy with natural orifice vs abdominal wall extraction: a single-institution analysis. Surg Endosc. 2025. PMID: 40825895. doi:10.1007/s00464-025-12062-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。